Potential Medicare Savings From Generic Substitution and Therapeutic Interchange of ACE Inhibitors and Angiotensin-II-Receptor Blockers.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 31380893.
- Also identified by DOI 10.1001/jamainternmed.2019.3107 and PMC identifier 6686978.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This economic evaluation study estimates the potential Medicare savings from generic substitution and therapeutic interchange of brand-name hypertension medications.
Medical subject headings
- Angiotensin Receptor Antagonists
- Angiotensin-Converting Enzyme Inhibitors
- Antihypertensive Agents
- Drug Substitution
- Drugs, Generic
- Hypertension